blue chip stocks
Get trusted blue chip stocks advice, news and features. Find blue chip stocks tips and insights to further your knowledge on kiplinger.com.
Latest
-
Closing Bell 7/22/20: Dow Edges Higher Despite Growing Rift With China
Markets The Dow and other major indices eked out gains Wednesday despite new wrinkles in U.S.-China relations; Tesla (TSLA) surges in after-hours action.
By Kyle Woodley Published
Markets -
Closing Bell 7/21/20: Energy Stocks Take a Turn in the Spotlight
Markets Exxon Mobil (XOM) and Chevron (XOM) led a big Tuesday for energy stocks and other cyclical sectors, and lifted the Dow to modest gains.
By Kyle Woodley Published
Markets -
Closing Bell 7/20/20: Amazon.com Goes Gonzo, Nasdaq Sets New High
Markets Amazon.com (AMZN) and Tesla (TSLA) sprinted to large gains Monday, launching the Nasdaq to fresh highs and putting the S&P 500 above breakeven for 2020.
By Kyle Woodley Published
Markets -
Closing Bell 7/17/20: Markets Close Mixed to End the Week
Markets The major indices went their different ways but were little changed Friday.
By Dan Burrows Published
Markets -
6 Dow Stocks With Yields of 4%+
dividend stocks Some high-yield Dow dividend stocks deserve a closer look, analysts say, but others aren't worth the trouble.
By Dan Burrows Published
dividend stocks -
Closing Bell 7/16/20: Stocks Step Back
Markets Rising cases of coronavirus across the U.S. and elevated first-time unemployment claims weighed on the market.
By Dan Burrows Published
Markets -
Closing Bell 7/14/20: Momentum Swings the Dow's Way
Markets Many of the Dow Jones' economically sensitive components pushed higher on Tuesday on the back of slightly better COVID-19 data from a few U.S. hotspots.
By Kyle Woodley Published
Markets -
Closing Bell 7/13/20: This Is Your Market on (Coronavirus) Drugs
Markets A rapid rally to start the week, sparked by encouraging vaccine news from Pfizer and BioNTech, collapsed in the afternoon.
By Kyle Woodley Published
Markets -
Closing Bell 7/10/20: Gilead Gives Stocks a Booster Shot
Markets Stocks rallied out of negative territory Friday after Gilead announced that remdesivir helped reduce COVID-19 mortality risk in a clinical trial.
By Kyle Woodley Published
Markets